share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga ·  May 17 20:07

Gainers

  • Akanda (NASDAQ:AKAN) shares rose 177.7% to $0.37 during Friday's pre-market session. The company's market cap stands at $11.7 million.
  • Scorpius Holdings (AMEX:SCPX) stock increased by 28.17% to $0.13. The market value of their outstanding shares is at $4.6 million.
  • NovaBay Pharmaceuticals (AMEX:NBY) shares moved upwards by 27.0% to $0.15. The market value of their outstanding shares is at $5.7 million.
  • ZimVie (NASDAQ:ZIMV) shares moved upwards by 23.61% to $20.99. The company's market cap stands at $572.7 million.
  • Kintara Therapeutics (NASDAQ:KTRA) stock moved upwards by 17.16% to $0.17. The market value of their outstanding shares is at $6.6 million. As per the press release, Q3 earnings came out 3 days ago.
  • Doximity (NYSE:DOCS) shares increased by 15.62% to $27.45. The company's market cap stands at $5.1 billion. The company's, Q4 earnings came out yesterday.

Losers

  • Reneo Pharmaceuticals (NASDAQ:RPHM) stock fell 13.8% to $1.43 during Friday's pre-market session. The market value of their outstanding shares is at $47.8 million.
  • Lucy Scientific Discovery (NASDAQ:LSDI) shares fell 11.33% to $1.41. The company's market cap stands at $2.4 million.
  • SINTX Techs (NASDAQ:SINT) shares declined by 10.01% to $0.13. The market value of their outstanding shares is at $15.4 million. The company's, Q1 earnings came out 4 days ago.
  • 180 Life Sciences (NASDAQ:ATNF) stock declined by 9.1% to $1.5. The market value of their outstanding shares is at $1.3 million. The company's, Q1 earnings came out 2 days ago.
  • Dynatronics (NASDAQ:DYNT) shares decreased by 8.43% to $0.4. The company's market cap stands at $2.1 million.
  • Protalix BioTherapeutics (AMEX:PLX) stock declined by 7.7% to $1.08. The company's market cap stands at $79.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment